Cargando…

Analysis of US County Characteristics and Clinicians With Waivers to Prescribe Buprenorphine After Changes in Federal Education Requirements

This cross-sectional study investigates the growth in the number of clinicians in the US who obtained waivers for prescribing buprenorphine after the elimination of federal educational requirements.

Detalles Bibliográficos
Autores principales:	Nguyen, Thuy, Andraka-Christou, Barbara, Arnaudo, Camila, Bradford, W. David, Simon, Kosali, Spetz, Joanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587475/ https://www.ncbi.nlm.nih.gov/pubmed/36269358 http://dx.doi.org/10.1001/jamanetworkopen.2022.37912

Ejemplares similares

Trends in Buprenorphine Coverage and Prior Authorization Requirements in US Commercial Formularies, 2017-2021
por: Nguyen, Thuy D., et al.
Publicado: (2022)

Changes in US Clinician Waivers to Prescribe Buprenorphine Management for Opioid Use Disorder During the COVID-19 Pandemic and After Relaxation of Training Requirements
por: Spetz, Joanne, et al.
Publicado: (2022)

Monthly Patient Volumes of Buprenorphine-Waivered Clinicians in the US
por: Duncan, Alexandra, et al.
Publicado: (2020)

State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements
por: Silwal, Anita, et al.
Publicado: (2023)

Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver
por: Lanham, Holly J., et al.
Publicado: (2022)

Characteristics and Prescribing Patterns of Clinicians Waivered to Prescribe Buprenorphine for Opioid Use Disorder Before and After Release of New Practice Guidelines
por: Jones, Christopher M., et al.
Publicado: (2023)

Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program
por: Rowe, Christopher L., et al.
Publicado: (2022)

Comparison of Rural vs Urban Direct-to-Physician Commercial Promotion of Medications for Treating Opioid Use Disorder
por: Nguyen, Thuy, et al.
Publicado: (2019)

Variations in national availability of waivered buprenorphine prescribers by racial and ethnic composition of zip codes
por: Hirchak, Katherine A., et al.
Publicado: (2022)

Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for Treatment
por: Arnaudo, Camila L., et al.
Publicado: (2017)

Buprenorphine Waiver Attitudes Among Primary Care Providers
por: Lai, Benjamin, et al.
Publicado: (2022)

Buprenorphine involvement in opioid overdose deaths: A retrospective analysis of postmortem toxicology in Marion County, Indiana, 2015-2021
por: del Pozo, Brandon, et al.
Publicado: (2023)

Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees
por: Wen, Hefei, et al.
Publicado: (2018)

Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants
por: Andraka-Christou, Barbara, et al.
Publicado: (2022)

Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment
por: Stein, Bradley D., et al.
Publicado: (2023)

Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018
por: Golan, Olivia K., et al.
Publicado: (2023)

Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic
por: Jones, Christopher M., et al.
Publicado: (2021)

Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic
por: Nguyen, Thuy, et al.
Publicado: (2022)

Association of Project ECHO Training With Buprenorphine Prescribing by Primary Care Clinicians in Minnesota for Treating Opioid Use Disorder
por: Solmeyer, Anna R., et al.
Publicado: (2022)

Trends in Buprenorphine Prescribing for Opioid Use Disorder by Psychiatrists in the US From 2003 to 2021
por: Creedon, Timothy B., et al.
Publicado: (2023)

Implementation of Federal Waivers for Feeding Children in Early Care and Education During the COVID-19 Pandemic
por: Dev, Dipti A., et al.
Publicado: (2022)

Training Clinicians to Support Aging in Place in a Medicaid Home and Community-Based Waiver Program
por: Spoelstra, Sandra, et al.
Publicado: (2020)

US Support for a WTO Waiver of COVID-19 Intellectual Property
por: Contreras, Jorge L.
Publicado: (2021)

Get waivered remote: Nationwide, remote DEA-x waiver course in response to COVID-19
por: Martin, Alister, et al.
Publicado: (2021)

The pressing shortage of buprenorphine prescribers and the pending role of telemedicine
por: Molfenter, Todd
Publicado: (2015)

Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries
por: Wheelock, Kevin M., et al.
Publicado: (2021)

A Descriptive Study on Opioid Misuse Prevalence and Office-Based Buprenorphine Access in Ohio Prior to the Removal of the Drug Addiction Treatment Act of 2000 Waiver
por: McKnight, Erin R, et al.
Publicado: (2023)

Self-reported Use of Prescribed Buprenorphine Among US Adults With Nonmedical Use of Prescription Opioids Motivated by Pain
por: Buonora, Michele J., et al.
Publicado: (2022)

Home and Community-Based Services Waivers
por: Duckett, Mary Jean, et al.
Publicado: (2000)

US Health Care Workforce Changes During the First and Second Years of the COVID-19 Pandemic
por: Cantor, Jonathan, et al.
Publicado: (2022)

Efficient burdens decrease nonmedical exemption rates: A cross-county comparison of Michigan’s vaccination waiver education efforts
por: Navin, Mark C., et al.
Publicado: (2020)

Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper
por: Bozinoff, Nikki, et al.
Publicado: (2022)

Barriers and Facilitators to Clinician Readiness to Provide Emergency Department–Initiated Buprenorphine
por: Hawk, Kathryn F., et al.
Publicado: (2020)

Attending a Biopsychosocially Focused Buprenorphine Training Improves Clinician Attitudes
por: Russell, Holly Ann, et al.
Publicado: (2021)

An Analysis of Primary Care Clinician Communication About Risk, Benefits, and Goals Related to Chronic Opioid Therapy
por: Danielson, Elizabeth C., et al.
Publicado: (2019)

State Health Reform and the Role of 1115 Waivers
por: Riley, Trish
Publicado: (1995)

Impact of the Maine Medicaid waiver for the mentally retarded
por: Coburn, Andrew F., et al.
Publicado: (1990)

Clinical trials waiver in India-some considerations
por: Juneja, Atul, et al.
Publicado: (2018)

Factors Influencing Buprenorphine Prescribing among Physicians in New York State
por: Marino, Leslie A., et al.
Publicado: (2019)

National trends in buprenorphine prescribing before and during the COVID-19 pandemic
por: Ali, Mir M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_27gba44vq07i4u69bm6kiss2is